How is medication overuse headache diagnosed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnosis of Medication Overuse Headache

Medication overuse headache is diagnosed when a patient with a pre-existing headache disorder has headache on ≥15 days per month for >3 months AND regularly overuses acute headache medication for >3 months, with specific thresholds: ≥15 days/month for simple analgesics (NSAIDs, acetaminophen) or ≥10 days/month for triptans, combination analgesics, ergots, or opioids 1.

Diagnostic Criteria (ICHD-3)

The diagnosis requires three essential components 1:

  1. Headache frequency: Headache occurring on ≥15 days per month in someone with a pre-existing headache disorder (typically migraine or tension-type headache)

  2. Medication overuse pattern for >3 months:

    • Simple analgesics (NSAIDs, acetaminophen): ≥15 days/month
    • Triptans: ≥10 days/month
    • Combination analgesics: ≥10 days/month
    • Ergots: ≥10 days/month
    • Opioids: ≥10 days/month
  3. Not better explained by another ICHD-3 diagnosis

Key Clinical Features to Identify

When taking the history, specifically document 2:

  • Headache frequency: Count exact number of headache days per month over the past 3 months
  • Medication use pattern: Document which medications, how many days per month, and for how long
  • Pre-existing headache disorder: Confirm the patient had migraine or another primary headache before the pattern of frequent headaches developed
  • Temporal relationship: The headache frequency increased as medication use increased

High-Risk Factors to Screen For

The 2024 VA/DoD guidelines identify specific risk factors that should raise suspicion 3:

Highest priority risk factors (in order of impact):

  • Headache frequency ≥7 days/month
  • Migraine diagnosis
  • Frequent use of anxiolytics, analgesics (including opioids), or sedative-hypnotics
  • History of anxiety or depression, especially with musculoskeletal or GI symptoms
  • Physical inactivity
  • Sick leave >2 weeks in past year
  • Self-reported whiplash
  • Tobacco use

Practical Diagnostic Approach

Step 1: Obtain detailed medication history

  • Ask specifically: "How many days per month do you take medication for headache?"
  • Document each medication type separately
  • Include over-the-counter medications, caffeine-containing products

Step 2: Use a headache diary prospectively

  • Have patient track headache days and medication use for 1 month
  • This confirms the diagnosis and establishes baseline 1

Step 3: Verify pre-existing headache disorder

  • Confirm patient had episodic migraine or tension-type headache before chronic pattern developed
  • Review whether attacks met ICHD-3 criteria for the primary headache type

Step 4: Apply medication-specific thresholds

  • Count days of use per month, not number of doses
  • Different medications have different thresholds (15 vs 10 days)

Critical Pitfall to Avoid

Do not confuse medication overuse headache with chronic migraine 1. Chronic migraine is defined as headache on ≥15 days/month with migraine features on ≥8 days/month, but does NOT require medication overuse. A patient can have chronic migraine without MOH, or both conditions simultaneously. The key distinguishing feature is the pattern of regular medication overuse for >3 months 1.

Clinical Considerations

The most recent ACP guideline emphasizes patient education about MOH as part of migraine management 2. Patients should be counseled that MOH is a potential complication when they begin acute migraine treatment, with clear thresholds provided (≥15 days/month for NSAIDs; ≥10 days/month for triptans).

The diagnosis is primarily clinical and does not require neuroimaging or other testing unless red flags for secondary headache are present 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.